top of page
Solgenics Logo
INVESTORS 3 BG.jpg

Investors

*Scott Fletcher also holds 15,936,000 warrant instruments, which if exercised, would take his holding to 33.4% of the company’s enlarged share capital, assuming that no other warrants are exercised.

**Seritza Limited is a private company owned by a trust of which Chief Executive Officer, Hanno Pengilly, is a potential beneficiary.

*** Michael Haworth SGN's non-executive chairman holds 10,826,416 shares in his own name and 13,110,133 through a trust. He also holds 3,264,000 warrant instruments, which if exercised, would take his holding to 4.8% of the company’s enlarged share capital, assuming that no other warrants are exercised.

****Mrs & Mr Weatherhead also hold 2,307,700 warrant instruments, which if exercised, would take their holding to 3.66% of the company’s enlarged share capital, assuming that no other warrants are exercised.

Shares Information

Scott Fletcher*

173,267,036

30.59%

9.71%

54,988,520

Africa Finance Corporation

9.46%

53,580,573

Seritza Limited**

4.23%

Michael Haworth***

Mrs & Mr Weatherhead****

18,428,044

3.25%

23,936,549

Significant Shareholders

learn more...

As at: 7 June 2023

566,501,146

Shares with voting rights

Shares in issue

566,501,146

Shares not in public hands

36.04%

Nominated Adviser and Broker

Liberum Capital Limited

Ropemaker Place Level 12

12 Ropemaker Street

London EC2Y 9AR

United Kingdom

Contacts

Broker

Novum Securities Limited

8-10 Grosvenor Gardens

London SW1W 0DH

United Kingdom

Registrar

Computershare Investor Services (BVI) Limited

Woodbourne Hall

PO Box 3162

Road Town Tortola

British Virgin Islands

Depositary

Computershare Investor Services plc

The Pavilions

Bridgwater Road

Bristol BS13 8AE

United Kingdom

Auditors

BDO LLP

55 Baker Street

London W1U 7EU

United Kingdom

Legal (UK)

Simmons & Simmons LLP

Citypoint

1 Ropemaker Street

London

EC2Y 9SS

United Kingdom

Legal (BVI)

Ogier

41 Lothbury

London EC2R 7HF

United Kingdom

Enviromental & Social

Impacto Av. Mártires da Machava,

968 Maputo, Mozambique

Investor Relations

Elizabeth Johnson

Tel:+44 (0) 777 565 5927

Email:info@solgenics.com

Registered Office

Coastal Building, Wickham's Cay II
PO Box 2221
Tortola
British Virgin Islands

Webcasts

Name

+
-

AIM Rule 26

Last updated: 6 March 2023

Company Information Disclosure

The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies.

Business Description

Please follow this link for a description of the business. Incorporation and Operation Solgenics Limited was incorporated in the British Virgin Islands (registration number 1019077) as a BVIBC with limited liability under the BVI act. Its main country of operation is Mozambique.

 

The rights of shareholders may be different from the rights of shareholders in a UK incorporated company. Solgenics Limited is not subject to the City Code on Takeovers and Mergers.

 

Please follow this link for a copy of the current memorandum and articles of association (PDF 421 KB). Directors Please follow this link for the names of the Directors and their biographies. Corporate governance and internal controls

 

Please follow this link for details of the responsibilities of the Board, corporate governance committees and Solgenics' compliance with the UK Combined Code.

 

Securities Information

Exchanges and Platforms Solgenics ordinary shares are admitted to trading on the AIM. The Company has not applied to have any of its securities admitted on any other exchange.

 

Securities in Issue

Please follow this link to access the securities in issue

 

Securities not in Public Hands

Please follow this link to access the securities in issue

 

Significant Shareholders (as at 9 February 2023)

Please follow this link to access the significant shareholders

 

Restrictions on Transfer

There are currently no restrictions on the transfer of securities.

 

Documentation and Announcements

 

Admission Document

Please follow this link to access the AIM admission document (PDF 20.3MB).

 

Shareholder Circulars

Access all circulars and similar publications sent to shareholders within the past 12 months.

 

Regulatory Announcements

Access all notifications made it the past 12 months.

 

Accounts

Access all the Company's financial statements here.

 

Advisers

Read more about details of Solgenics’ nominated adviser and other key advisors below

-
+
Recent
Archive
Recent
Archive

News

-
+
Recent
Archive
Recent
Archive

Reports

-
+

Presentations

Recent
Archive
Recent
Archive
-
+

General Meetings

Recent
Archive
Recent
Archive
-
+
bottom of page